Company Overview
ACTINIUM PHARMACEUTICALS, INC.
ATNMRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
0M
2025 FY
Net Income
-34M
2025 FY
Shares Outstanding
31M
2025 FY
EPS
-1.09USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1388320
Exchange
NYSE
Location
US